Top Markets
Coin of the day
Xcell Therapeutics, Inc. Xcell Therapeutics, Inc.

Xcell Therapeutics, Inc.

373110
Clasificación en acciones #30829
Xcell Therapeutics Inc. engages in the development and production of drugs for... Xcell Therapeutics Inc. engages in the development and production of drugs for cell therapy. It offers CellCor, a serum-free chemically defined medium that is used to develop human mesenchymal stem cells. The company also offers XPorT, a platform that aims to develop optimal media from the perspective of the user using a variety of cells. In addition, it develops media for cell culture in various areas of the bioindustry such as cell therapy, gene therapy, exosomes, organoids and bioreactors. Xcell Therapeutics Inc. was founded in 2015 and is based in Seoul, South Korea.
Precio por acción
$0.88649477
Capitalización bursátil
$15.33M
Cambio (1 día)
-3.61%
Cambio (1 año)
-54.45%
País
KR
Comercio Xcell Therapeutics, Inc. (373110)

Categoría

Historial de rendimiento por dividendo de Xcell Therapeutics, Inc. (373110)
Rendimiento por dividendo (TTM) de Xcell Therapeutics, Inc. (símbolo bursátil: 373110) al 2026: 0
Rendimiento promedio por dividendo de los últimos 5 años: 0.00%
Historial de rendimiento por dividendo de Xcell Therapeutics, Inc. (373110) desde 2026 hasta 2026
Rendimiento por dividendo al final de cada año (TTM)
Año Rendimiento por dividendo Cambiar
Not enough data for the provided dates.
Rendimientos por dividendo (TTM) de empresas similares o competidoras
Empresa Rendimiento por dividendo País
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH
0.00%
KR